Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.

Marino N, Marshall JC, Steeg PS.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Oct;384(4-5):351-62. doi: 10.1007/s00210-011-0646-6. Epub 2011 Jun 29. Review.

PMID:
21713383
2.

Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma.

Novak M, Jarrett SG, McCorkle JR, Mellon I, Kaetzel DM.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Oct;384(4-5):433-8. doi: 10.1007/s00210-011-0621-2. Epub 2011 Mar 30. Review.

PMID:
21448569
3.

Regulators affecting the metastasis suppressor activity of Nm23-H1.

Kim HD, Youn B, Kim TS, Kim SH, Shin HS, Kim J.

Mol Cell Biochem. 2009 Sep;329(1-2):167-73. doi: 10.1007/s11010-009-0109-2. Epub 2009 Apr 18. Review.

PMID:
19377884
4.

[NM23, an example of a metastasis suppressor gene].

Boissan M, Lacombe ML.

Bull Cancer. 2012 Apr 1;99(4):431-40. doi: 10.1684/bdc.2012.1550. Review. French.

5.

Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Marino N, Nakayama J, Collins JW, Steeg PS.

Cancer Metastasis Rev. 2012 Dec;31(3-4):593-603. doi: 10.1007/s10555-012-9374-8. Review.

PMID:
22706779
7.

Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.

McDermott WG, Boissan M, Lacombe ML, Steeg PS, Horak CE.

Clin Exp Metastasis. 2008;25(2):131-8. Epub 2007 Dec 5.

PMID:
18058029
8.

Potential roles of 3'-5' exonuclease activity of NM23-H1 in DNA repair and malignant progression.

Kaetzel DM, Zhang Q, Yang M, McCorkle JR, Ma D, Craven RJ.

J Bioenerg Biomembr. 2006 Aug;38(3-4):163-7. Review.

PMID:
17039395
9.

Nm23-H1 promotes adhesion of CAL 27 cells in vitro.

Bago R, Pavelić J, Maravić Vlahovicek G, Bosnar MH.

Mol Carcinog. 2009 Sep;48(9):779-89. doi: 10.1002/mc.20536.

PMID:
19263457
10.

Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.

Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS.

Cancer Res. 2007 Aug 1;67(15):7238-46.

12.
13.

Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue.

Andolfo I, De Martino D, Liguori L, Petrosino G, Troncone G, Tata N, Galasso A, Roma C, Chiancone F, Zarrilli S, Arrigoni G, Staibano S, Imbimbo C, Zollo M.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Oct;384(4-5):489-98. doi: 10.1007/s00210-011-0645-7. Epub 2011 May 7.

PMID:
21553004
14.

Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.

Wang YF, Chen JY, Chang SY, Chiu JH, Li WY, Chu PY, Tai SK, Wang LS.

Int J Cancer. 2008 Jan 15;122(2):377-86.

15.

Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.

Zhang Q, McCorkle JR, Novak M, Yang M, Kaetzel DM.

Int J Cancer. 2011 Jan 1;128(1):40-50. doi: 10.1002/ijc.25307.

16.

nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.

Russell RL, Geisinger KR, Mehta RR, White WL, Shelton B, Kute TE.

Cancer. 1997 Mar 15;79(6):1158-65.

PMID:
9070493
17.
18.

Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.

Aktary Z, Chapman K, Lam L, Lo A, Ji C, Graham K, Cook L, Li L, Mackey JR, Pasdar M.

Oncogene. 2010 Apr 8;29(14):2118-29. doi: 10.1038/onc.2009.495. Epub 2010 Jan 25.

PMID:
20101217
19.

Nm23-H1 can induce cell cycle arrest and apoptosis in B cells.

Choudhuri T, Murakami M, Kaul R, Sahu SK, Mohanty S, Verma SC, Kumar P, Robertson ES.

Cancer Biol Ther. 2010 Jun 15;9(12):1065-78. Epub 2010 Jun 11.

PMID:
20448457
20.

Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.

Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.

Cancer Res. 2001 Mar 1;61(5):2320-7.

Supplemental Content

Support Center